Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation

International Journal of Neuroscience

Volumn 130, Issue 11, 2020, Pages 1095-1100

  Güneş, Muzaffer ^a   Büyükgöl, Hüseyin ^b  

^a AKSARAY UNIVERSITY   (Turkey)

^b KTO KARATAY UNIVERSITY   (Turkey)

Author keywords

epileptic seizure; generalized epilepsy; neutrophil lymphocyte ratio; platelet lymphocyte ratio; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INFLAMMATION; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; RISK ASSESSMENT; TONIC CLONIC SEIZURE; ACUTE DISEASE; BLOOD; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; LEUKOCYTE COUNT; LYMPHOCYTE; PATHOPHYSIOLOGY; PLATELET COUNT; RISK; THROMBOCYTE;

ACUTE DISEASE; ADULT; BLOOD PLATELETS; C-REACTIVE PROTEIN; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; RISK;

EID: 85079046270     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207454.2020.1722662     Document Type: Article

References (32)

1. Duncan JS. Seizure-induced neuronal injury: human data. Neurology. 2002;59(Issue 9, Supplement 5):S15–S20.
2. Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci. 2014;37(2):55–65.
3. Panayiotopoulos CP. The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia. 2012;53(3):399–404.
4. Ravizza T, Gagliardi B, Noe F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;29(1):142–160.
5. Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother. 2015;15(9):1081–1092.
6. Sutter R, Grize L, Fuhr P, et al. Acute-phase proteins and mortality in status epilepticus: a 5 year observational cohort study. Crit Care Med. 2013;41(6):1526–1533.
7. Marchi N, Fan Q, Ghosh C, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis. 2009;33(2):171–181.
8. Marchi N, Granata T, Freri E, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One. 2011;6(3):e18200.
9. Wengner AM, Pitchford SC, Furze RC, et al. The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood. 2008;111(1):42–49.
10. Summers C, Rankin SM, Condliffe AM, et al. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31(8):318–324.
11. Zahorec R. Ratio of neutrophil to lymphocyte counts rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
12. Yang DH, Qian MZ, Wei MM, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;8(44):76099–76107.
13. Huang Y, Ying Z, Quan W, et al. The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barré syndrome. Int J Neurosci. 2018;128(8):729–735.
14. Giede-Jeppe A, Bobinger T, Gerner ST, et al. Neutrophil-to-lymphocyte ratio is an independent predictor for in-hospital mortality in spontaneous intracerebral hemorrhage. Cerebrovasc Dis. 2017;44(1-2):26–34.
15. Yu S, Arima H, Bertmar C, et al. Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci. 2018;387:115–118.
16. Tahto E, Jadric R, Pojskic L, et al. Neutrophil-to-lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome. Med Arch. 2017;71(5):312–315.
17. Özdemir HH, Akil E, Acar A, et al. Changes in serum albumin levels and neutrophil-lymphocyte ratio in patients with convulsive status epilepticus. Int J Neurosci. 2017;127(5):417–420.
18. Yiğit Y, Yilmaz S, Akdoğan A, et al. The role of neutrophil-lymphocyte ratio and red blood cell distribution width in the classification of febrile seizures. Eur Rev Med Pharmacol Sci. 2017;21(3):554–559.
19. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512–521.
20. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530.
21. Vezzani A, Maroso M, Balosso S, et al. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun. 2011;25(7):1281–1289.
22. Zhang J, Ren Q, Song Y, et al. Prognostic role of neutrophil lymphocyte ratio in patients with acute ischemic stroke. Medicine (Baltimore). 2017;96(45):e8624.
23. Ye Z, Ai X, Fang F, et al. The use of neutrophil to lymphocyte ratio as a predictor for clinical outcomes in spontaneous intracerebral hemorrhage. Oncotarget. 2017;8(52):90380–90389.
24. Lattanzi S, Cagnetti C, Provinciali L, et al. Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage. Stroke. 2016;47(6):1654–1657.
25. ́ syndrome. J Child Neurol. 2018;33((2):164–167.
26. Xu T, Weng Z, Pei C, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus. Medicine (Baltimore). 2017;96(45):e8289.
27. Chen W, Yang J, Li B, et al. Neutrophil to lymphocyte ratio as a novel predictor of outcomein patients with severe traumatic brain injury. J. Head Trauma Rehabil. 2018;33(1):E53–E59.
28. Chae S, Kang KM, Kim HJ, et al. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer. Curr Oncol. 2018;25(2):e113–e119.
29. Vano YA, Oudard S, By MA, et al. Optimal cut-off for neutrophil-to-lymphocyte ratio: fact or fantasy? A prospective cohort study in metastatic cancer patients. PLoS One. 2018;13(4):e0195042.
30. Yu Y, Wang H, Yan A, et al. Pretreatment neutrophil to lymphocyte ratio in determin-ing the prognosis of head and neck cancer: a meta-analysis. BMC Cancer. 2018;18(1):383.
31. Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presenceand severity of Behçet’s syndrome. Kaohsiung J Med Sci. 2015;12:626–631.
32. Yazici S, Yazici M, Erer B, et al. The platelet functions in patients with ankylosing spondylitis, anti- TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets. 2010;21(2):126–131.